Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
Monster Beverage
MNST
|
+$584M |
| 3 |
Intercontinental Exchange
ICE
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$386M |
| 5 |
Johnson & Johnson
JNJ
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$750M |
| 3 |
Deere & Co
DE
|
+$539M |
| 4 |
Microsoft
MSFT
|
+$507M |
| 5 |
Meta Platforms (Facebook)
META
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.99% |
| 2 | Healthcare | 19.86% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
276
DELISTED
Altair Engineering Inc
ALTR
| $102M | 0.05% |
1,070,621
+1,799
| +0.2% | +$163K |
|
277
Geron
GERN
$930M
| $102M | 0.05% |
22,565,846
+13,163,889
| +140% | +$59.9M |
|
278
Ligand Pharmaceuticals
LGND
$5.94B
| $101M | 0.05% |
1,009,094
+361
| +0% | +$36.3K |
|
279
Xenon Pharmaceuticals
XENE
$6.28B
| $101M | 0.05% |
2,552,392
+1,507,135
| +144% | +$60.8M |
|
280
Constellium
CSTM
$3.96B
| $100M | 0.05% |
6,152,955
+971
| +0% | +$16.5K |
|
281
Stride
LRN
$4.08B
| $99.9M | 0.05% |
1,170,434
+13,050
| +1% | +$1.01M |
|
282
NeoGenomics
NEO
$1.74B
| $97.4M | 0.05% |
6,603,180
-16,156
| -0.2% | -$253K |
|
283
Spotify
SPOT
$105B
| $97.3M | 0.05% |
264,233
+257,706
| +3,948% | +$85.7M |
|
284
AST SpaceMobile
ASTS
$16.9B
| $94.9M | 0.05% |
3,629,085
-3,825,815
| -51% | -$86.3M |
|
285
CACI
CACI
$11.3B
| $94.3M | 0.05% |
186,964
-449
| -0.2% | -$208K |
|
286
Donaldson
DCI
$11.1B
| $94M | 0.05% |
1,274,771
-113,729
| -8% | -$8.22M |
|
287
AvalonBay Communities
AVB
$27.2B
| $93.8M | 0.05% |
416,461
+43,206
| +12% | +$9.33M |
|
288
Cencora
COR
$62.2B
| $93.1M | 0.05% |
413,437
-502,541
| -55% | -$117M |
|
289
Advanced Drainage Systems
WMS
$11.1B
| $92.6M | 0.05% |
589,140
+953
| +0.2% | +$149K |
|
290
Neurocrine Biosciences
NBIX
$18.4B
| $91.3M | 0.05% |
792,196
-179,007
| -18% | -$24.5M |
|
291
Mirion Technologies
MIR
$4.11B
| $89.7M | 0.05% |
8,100,777
-584,490
| -7% | -$6.15M |
|
|
APLT
292
DELISTED
Applied Therapeutics
APLT
| $89.7M | 0.05% |
10,541,528
+2,893,323
| +38% | +$17.1M |
|
293
Clarivate
CLVT
$1.53B
| $89.2M | 0.05% |
12,565,739
-1,679,043
| -12% | -$10.7M |
|
294
Equity Lifestyle Properties
ELS
$12.8B
| $87.2M | 0.04% |
1,221,850
-10,210
| -0.8% | -$716K |
|
295
Cullen/Frost Bankers
CFR
$10.5B
| $86.9M | 0.04% |
777,082
-46,061
| -6% | -$5.04M |
|
296
Wynn Resorts
WYNN
$10.3B
| $86.6M | 0.04% |
902,880
-165,706
| -16% | -$13.3M |
|
297
Teva Pharmaceuticals
TEVA
$36.9B
| $86.4M | 0.04% |
4,791,937
+4,732,374
| +7,945% | +$82.8M |
|
298
Saia
SAIA
$10.9B
| $86M | 0.04% |
196,784
-517
| -0.3% | -$219K |
|
299
Aptiv
APTV
$12.6B
| $85.8M | 0.04% |
1,190,661
-175,579
| -13% | -$12.3M |
|
300
Paylocity
PCTY
$7.43B
| $85.4M | 0.04% |
517,931
+17,560
| +4% | +$2.67M |
|
Similar funds
Janus Henderson Group's Q3 2024 Portfolio in Review
As of Q3 2024, Janus Henderson Group held 2,584 positions worth $195B, up 4.6% from $187B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.7%. Janus Henderson Group opened 66 new positions and exited 56, leaving the 2,584-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2024 buy was Janus Henderson Emerging Markets Debt Hard Currency ETF: 4,369,165 shares worth $228M.
- Janus Henderson Group added most to Broadcom in Q3 2024, an estimated $605M increase.
- Janus Henderson Group's biggest Q3 2024 reduction was Texas Instruments, cutting an estimated $750M.
- Janus Henderson Group fully exited Lam Research in Q3 2024, selling an estimated $1.95B.
- Janus Henderson Group's ten largest holdings make up 30% of its $195B portfolio in Q3 2024.
- Janus Henderson Group opened 66 new positions and closed 56 in Q3 2024.
- Janus Henderson Group's portfolio value rose 4.6% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.